Home>Topics>Companies>Reckitt Benckiser

Reckitt Benckiser

  1. All
  2. Commentary
  3. Headlines
  1. Reckitt Chalks Up Solid Start to Year Behind Strong Flu Season; Shares Modestly Overvalued

    Commentary

    Fri, 24 Apr 2015

    An intense cold and flu season proved advantageous for Reckitt Benckiser through the first three months of the year, as underlying sales ticked up more 5% year over year. Sales in the health segment

  2. UPDATE 1- Reckitt Benckiser reports sales gain, stands by full-year goal

    Headlines

    Fri, 24 Apr 2015

    LONDON, April 24 (Reuters) - Britain's Reckitt Benckiser Group reported higher quarterly sales on Friday, helped by growth across all regions, and stood by its full-year target.

  3. Reckitt Benckiser reports higher sales, stands by full-year target

    Headlines

    Fri, 24 Apr 2015

    LONDON, April 24 (Reuters) - Britain's Reckitt Benckiser Group reported higher quarterly sales on Friday, helped by growth across all regions, and stood by its full-year target.

  4. Reckitt Enhances CPG Focus With Planned Pharma Spin; Shares Modestly Overvalued

    Commentary

    Mon, 28 Jul 2014

    Even more notable than Reckitt Benckiser ’s first-half results--3% like-for-like sales growth and 10 basis points of adjusted operating margin contraction to

  5. UK's FTSE propped up by rally in Reckitt shares

    Headlines

    Mon, 28 Jul 2014

    LONDON, July 28 (Reuters) - Britain's top equity index crept higher on Monday, supported by solid results at consumer goods company Reckitt Benckiser which offset a slump at Aberdeen Asset...

  6. Reckitt helps keep Britain's FTSE afloat after solid update

    Headlines

    Mon, 28 Jul 2014

    * Reckitt Benckiser leads risers after solid update, disposal plan

  7. Reckitt Buys K-Y Brand in Move That Will Complement Existing Portfolio

    Commentary

    Mon, 10 Mar 2014

    Reckitt Benckiser today announced the acquisition of the global rights to the K-Y brand from Johnson & Johnson for an undisclosed amount. The

  8. Reckitt to Explore Strategic Alternatives for Pharmaceuticals Operations; Shares Fairly Valued

    Commentary

    Tue, 22 Oct 2013

    Reckitt Benckiser ’s third-quarter sales update showcased modest top-line underlying growth (3% in total, 5% excluding the pharmaceuticals segment

  9. Lingering Cold and Flu Season a Plus for Reckitt but Competitive Pressures Remain; Shares a Bit Rich

    Commentary

    Mon, 29 Jul 2013

    A strong cold and flu season propped up Reckitt Benckiser 's RB . first-half results (underlying sales up 6% year over year) . However, adjusted operating margins slipped 80 basis points

  10. Strong Cold and Flu Season Led to Healthy Top Line at Reckitt; Shares Not Overly Attractive

    Commentary

    Mon, 22 Apr 2013

    Despite the ills faced by consumers, Reckitt Benckiser RB . actually benefited from the strong cold and flu season, as evidenced in its first-quarter trading update. Adjusting for acquisitions

« Prev123Next »
Content Partners